NCT00255060已完成不适用
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
To screen women who are high risk for breast cancer with breast MRI, mammogram and random periareolar fine needle aspiration.
详细描述
General Purpose: The purpose of our protocol is develop a comprehensive screening protocol for women at high risk for developing breast cancer in the hopes of detecting breast cancer or it's precursor lesions at the earliest possible stage and reducing breast cancer mortality.
The following are our specific goals in this endeavor;
- To assess the sensitivity and specificity of MRI in breast cancer detection in women at high risk compared to mammography
- To assess the ability of random periareolar fine needle aspiration to detect abnormal ductal cells and to correlate these results with MRI and mammogram findings
- To assess appropriate screening intervals for BRCA1/2 mutation carriers and women with a >10% risk of developing breast cancer in ten years The following aims will be outlined in detail under methodology.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 25 Years 至 65 Years(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Subjects must be female, between the ages of 25 and 65, or ten years younger than the youngest breast cancer diagnosed in the family, or have no mutation identified but have a greater than 10% risk of developing breast cancer in ten years (based on the Claus Model).
- •May have had previous breast or ovarian cancer, but must be at least one year out from treatment of a Stage 1 or early 2 cancer.
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
High Risk Breast Cancer Screening ProgramBreast CancerNCT00509509Organisation for Oncology and Translational Research
已完成
不适用
Cancer Screening and Prevention Program for High Risk WomenBreast CancerOvarian CancerNCT00849199NYU Langone Health1,452
尚未招募
不适用
The preventing treatment of the breast cancer high risk case( the gene mutation positive case )The hereditariness breast cancer high risk groupJPRN-UMIN000013764Breast Disease Center, Asahikawa Medical University100
尚未招募
3 期
The genetic screening to the hereditariness breast cancer high risk groupThe hereditariness breast cancer high risk groupJPRN-UMIN000013763Department of Breast Disease Center, Asahikawa Medical University100
终止
不适用
Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation TherapyBreast CancerNCT00925405M.D. Anderson Cancer Center10
